Cargando…

CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them

Conventional therapies for acute myeloid leukemia (AML) are characterized by high rates of relapse, severe toxicities, and poor overall survival rates. Thus, the development of new therapeutic strategies is crucial for improving the survival and quality of life of AML patients. CD19-directed chimeri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanhooren, Jolien, Dobbelaere, Rani, Derpoorter, Charlotte, Deneweth, Larissa, Van Camp, Laurens, Uyttebroeck, Anne, De Moerloose, Barbara, Lammens, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479376/ https://www.ncbi.nlm.nih.gov/pubmed/37674860 http://dx.doi.org/10.1097/HS9.0000000000000937

Ejemplares similares

TARP as antigen in cancer immunotherapy
por: Vanhooren, Jolien, et al.
Publicado: (2021)

Deciphering the Non-Coding RNA Landscape of Pediatric Acute Myeloid Leukemia
por: Vanhooren, Jolien, et al.
Publicado: (2022)

Clinical Significance of TARP Expression in Pediatric Acute Myeloid Leukemia
por: Depreter, Barbara, et al.
Publicado: (2020)

Identification of barriers to insulin therapy and approaches to overcoming them
por: Russell‐Jones, David, et al.
Publicado: (2017)

Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
por: Al Ojaimi, Yara, et al.
Publicado: (2022)

Barriers to Sustained Implementation of STAR-VA and Strategies to Overcome Them
por: Sullivan, Jennifer, et al.
Publicado: (2021)

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
por: Depreter, Barbara, et al.
Publicado: (2020)

Genes at the Crossroad of Primary Immunodeficiencies and Cancer
por: Derpoorter, Charlotte, et al.
Publicado: (2018)

In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy
por: Xin, Tianqing, et al.
Publicado: (2022)

Virtual learning during the COVID-19 pandemic: What are the barriers and how to overcome them?
por: Khobragade, Sujata Yadneshwar, et al.
Publicado: (2021)

Donor support for Health Policy and Systems Research: barriers to financing and opportunities for overcoming them
por: Kentikelenis, Alexander, et al.
Publicado: (2022)

Acute myeloid leukemia therapeutics: CARs in the driver’s seat
por: Mardiros, Armen, et al.
Publicado: (2013)

Skin Barriers in Dermal Drug Delivery: Which Barriers Have to Be Overcome and How Can We Measure Them?
por: Gorzelanny, Christian, et al.
Publicado: (2020)

Role of Biomarkers in the Clinical Management of Glioblastomas: What are the Barriers and How Can We Overcome Them?
por: McDonald, Kerrie L., et al.
Publicado: (2013)

Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia
por: De Santis, Sara, et al.
Publicado: (2022)

CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
por: Mardiana, Sherly, et al.
Publicado: (2020)

CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia
por: Pasvolsky, Oren, et al.
Publicado: (2022)

A Panorama of Immune Fighters Armored with CARs in Acute Myeloid Leukemia
por: Christodoulou, Ilias, et al.
Publicado: (2023)

CAR-T Cells Immunotherapies for the Treatment of Acute Myeloid Leukemia—Recent Advances
por: Zarychta, Julia, et al.
Publicado: (2023)

P468: DETECTION AND CHARACTERIZATION OF RESIDUAL LEUKEMIC CELLS IN CHILDHOOD ACUTE MYELOID LEUKEMIA USING TARGETED DEEP SEQUENCING AND SINGLE CELL MULTI-OMICS
por: Saeed, Borhan R, et al.
Publicado: (2023)

Pitfalls of Echocardiographic Image Perception: How to Overcome Them?
por: Leitman, Marina, et al.
Publicado: (2022)

Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance
por: Åbacka, Hannah, et al.
Publicado: (2021)

Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia
por: Sharma, Priyanka, et al.
Publicado: (2023)

A novel approach to overcome drug resistance in acute myeloid leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
por: Wang, Jinghua, et al.
Publicado: (2018)

Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
por: Hofmann, Susanne, et al.
Publicado: (2019)

Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid Leukemia
por: Gurney, Mark, et al.
Publicado: (2021)

Driving CAR T Stem Cell Targeting in Acute Myeloid Leukemia: The Roads to Success
por: Michelozzi, Ilaria M., et al.
Publicado: (2021)

89723 CD105-targeted CAR T cells for the treatment of acute myeloid leukemia
por: Lontos, Konstantinos, et al.
Publicado: (2021)

Therapeutic targeting of PRAME with (mTCR)CAR T cells in acute myeloid leukemia
por: Kirkey, Danielle C., et al.
Publicado: (2022)

Valproic acid increases CAR T cell cytotoxicity against acute myeloid leukemia
por: Wen, Jingjing, et al.
Publicado: (2023)

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
por: Martínez Bedoya, Darel, et al.
Publicado: (2021)

Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring
por: Diez-Fraile, Araceli, et al.
Publicado: (2020)

Tracking the Molecular Fingerprint of Head and Neck Cancer for Recurrence Detection in Liquid Biopsies
por: Diez-Fraile, Araceli, et al.
Publicado: (2022)

Barriers to integration of behavioral and social sciences in the general medicine curriculum and recommended strategies to overcome them: A systematic review
por: TABATABAEI, ZAHRA, et al.
Publicado: (2016)

Cantharidin Overcomes Imatinib Resistance by Depleting BCR-ABL in Chronic Myeloid Leukemia
por: Sun, Xiaoyan, et al.
Publicado: (2016)

Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia
por: Qin, Lei, et al.
Publicado: (2016)

Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia
por: Zee, Barry M., et al.
Publicado: (2021)

An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia
por: Przedborski, Michelle, et al.
Publicado: (2022)

Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2
por: Xu, Xi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9cj4airra3n0i2gp9upg31915p